Vor to Participate in Two Upcoming Investor Conferences
Vor Biopharma (Nasdaq: VOR) announced participation in two virtual investor conferences. The first is the H.C. Wainwright BioConnect 2022, with a pre-recorded presentation available on January 10, 2022, starting at 7:00 AM ET. The second event is the 2022 B Riley Virtual Oncology Conference, featuring a live webcast fireside chat on January 27, 2022, at 10:30 AM ET. Both presentations will be accessible through the company’s website, along with archived replays.
Vor Biopharma focuses on engineering hematopoietic stem cells to improve blood cancer treatments.
- None.
- None.
CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that members of its senior management team will be participating in two upcoming virtual investor conferences:
H.C. Wainwright BioConnect 2022 Virtual Conference
Presentation Date: Monday, January 10, 2022
Time: Pre-recorded on-demand presentation available beginning at 7:00 AM ET
2022 B Riley Virtual Oncology Conference
Fireside Chat Live Webcast Date: Thursday, January 27, 2022
Time: 10:30 AM ET
The live and on demand webcasts of both presentations will be available on the Company's website at www.vobrbio.com. An archived replay of each webcast will also be available.
About Vor Biopharma
Vor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contacts:
Investors:
Chris Brinzey
ICR Westwicke
+1 339-970-2843
chris.brinzey@westwicke.com
Media:
Sarah Spencer
Vice President, Corporate Communications, Vor
+1 857-242-6076
sspencer@vorbio.com
FAQ
When is Vor Biopharma's presentation at the H.C. Wainwright BioConnect 2022 Conference?
What time does Vor Biopharma's fireside chat at the B Riley Virtual Oncology Conference start?
Where can I watch Vor Biopharma's presentations from the investor conferences?